Tranexamic acid trial for adults with sepsis in ICU
Treatments studied
Part of Infections clinical trials.
This trial studies whether early tranexamic acid (a medicine that can reduce bleeding) can change the body’s inflammatory response in people with sepsis. If it works, it may help improve outcomes for certain ICU patients—but you must meet specific safety and eligibility checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18–65.
- You have sepsis, defined by a screening score (qSOFA) of 2 or higher, and you need ICU admission.
- You do not have long-term kidney failure.
- You do not have liver cirrhosis.
- You cannot have bleeding risk issues, blood-thinning (anticoagulant) medicines, or a history of serious blood clots (like deep vein thrombosis or pulmonary embolism).
- You are not pregnant or breastfeeding, and you do not have an allergy to tranexamic acid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests if giving tranexamic acid (a medicine that helps blood clot) through a mist into the nose and sinuses during sinus surgery can reduce bleeding. It is designed for adults who are otherwise healthy and undergoing a common type of sinus surgery called functional endoscopic sinus surgery (FESS).
This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial tests if tranexamic acid, a medicine that helps blood clot, can safely reduce bleeding during adult liver transplant surgery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.